Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07228923

Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Treatment Seeking Smokers

Evaluation of a Theory Informed Intervention to Reduce Hazardous Alcohol Consumption Among Treatment Seeking Smokers

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
77 (estimated)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study will evaluate the implementation of a fully automated, direct-to-patient digital alcohol intervention embedded within the STOP Program's patient portal. The STOP Program is a large-scale, population-based smoking cessation initiative operating in over 300 primary care settings across Ontario. It provides free nicotine replacement therapy and behavioural support through a digital portal that facilitates patient self-enrollment and systematic data collection. As part of this study, patients who score ≥8 on the AUDIT-C will be offered the opportunity to view a brief intervention (BI). Those with an AUDIT-C score ≥10 will receive a cautionary message along with tailored content designed to help reduce hazardous drinking. The intervention was developed based on a rapid review (PROSPERO: CRD42023445492) and a Delphi consensus process using the Behaviour Change Techniques Taxonomy V1. Key components include personalized feedback, normative comparisons, reflective prompts, and actionable behaviour change strategies. For patients scoring above a clinical threshold, additional messaging encourages caution regarding abrupt cessation and suggests consulting a healthcare provider. Our primary outcome is acceptance of the new online resource.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrief alcohol interventionThe intervention is a prompt that that appears as an alert message in the patient portal, recommending the alcohol intervention.

Timeline

Start date
2025-11-20
Primary completion
2026-08-31
Completion
2026-12-31
First posted
2025-11-14
Last updated
2025-11-14

Source: ClinicalTrials.gov record NCT07228923. Inclusion in this directory is not an endorsement.